Clinical Safety, Tolerance, and Plasma Levels of the Oral Anticholinesterase 1,2,3,4-Tetrahydro-9-aminoacridin-1-oL-maleate (HP 029) in Alzheimer's Disease: Preliminary Findings-Reference-Cited by-同舟云学术

Clinical Safety, Tolerance, and Plasma Levels of the Oral Anticholinesterase 1,2,3,4-Tetrahydro-9-aminoacridin-1-oL-maleate (HP 029) in Alzheimer's Disease: Preliminary Findings

Published:1990-06 Issue:6 Volume:30 Page:556-561
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Cutler Neal R.,Murphy Michael F.,Nash Ralph J.,Prior Pat L.,De Luna Diane M.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/j.1552-4604.1990.tb03620.x/fullpdf

Reference16 articles.

1. Alzheimer's disease and senile dementia: Loss of neurons in the basal forebrain;Whitehouse;Science,1986

2. Muscarinic and choline acetyltransferase in postmortum brains of demented patients;Waller;Can J Neurol Sci,1986

3. Anticholinergic sensitivity in patients with dementia of the Alzheimer type and age-matched controls;Sunderland;Arch Gen Psychiatry,1987

4. Scopolamine and controls of attention in humans;Dunne;Psychopharmacology,1986

5. Physostigmine and arecholine: Effects of intravenous infusions in Alzheimer presenile dementia;Christie;Br J Psychiatry,1981

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Maximum Tolerated Dose Evaluation of the AMPA Modulator Org 26576 in Healthy Volunteers and Depressed Patients A Summary and Method Analysis of Bridging Research in Support of Phase II Dose Selection;DRUGS R&D;2012

2. Maximum Tolerated Dose Evaluation of the AMPA Modulator Org 26576 in Healthy Volunteers and Depressed Patients;Drugs in R&D;2012-09

3. Bridging and CSF Studies;Critical Pathways to Success in CNS Drug Development;2010-03-05

4. Informed consent in dementia research. Legislation, theoretical concepts and how to assess capacity to consent;European Geriatric Medicine;2010-02

5. Velnacrine for Alzheimer's disease;Cochrane Database of Systematic Reviews;2004-04-19